Education
About Us
Working with TipRanks
Follow Us
Enzymatica AB (SE:ENZY)
:ENZY
ENZY Stock Chart & Stats
kr1.84
-kr0.34(-10.43%)
At close: 4:00 PM EST
kr1.84
-kr0.34(-10.43%)
Day’s Range― - ―
52-Week Rangekr1.34 - kr5.45
Previous CloseN/A
Volume634.97K
Average Volume (3M)93.66K
Market Cap
kr446.63M
Enterprise Valuekr538.65M
Total Cash (Recent Filing)kr33.08M
Total Debt (Recent Filing)kr1.30M
Price to Earnings (P/E)―
Beta0.26
Next Earnings
Feb 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.03
Shares Outstanding242,735,100
10 Day Avg. Volume44,136
30 Day Avg. Volume93,658
Financial Highlights & Ratios
PEG Ratio0.00
Price to Book (P/B)1.73
Price to Sales (P/S)6.68
P/FCF Ratio-5.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
ENZY FAQ
What was Enzymatica AB’s price range in the past 12 months?
Enzymatica AB lowest stock price was kr1.34 and its highest was kr5.45 in the past 12 months.
What is Enzymatica AB’s market cap?
Enzymatica AB’s market cap is kr446.63M.
When is Enzymatica AB’s upcoming earnings report date?
Enzymatica AB’s upcoming earnings report date is Feb 18, 2026 which is in 64 days.
How were Enzymatica AB’s earnings last quarter?
Enzymatica AB released its earnings results on Oct 30, 2025. The company reported -kr0.03 earnings per share for the quarter, missing the consensus estimate of N/A by -kr0.03.
Is Enzymatica AB overvalued?
According to Wall Street analysts Enzymatica AB’s price is currently Overvalued.
Does Enzymatica AB pay dividends?
Enzymatica AB does not currently pay dividends.
What is Enzymatica AB’s EPS estimate?
Enzymatica AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Enzymatica AB have?
Enzymatica AB has 242,735,100 shares outstanding.
What happened to Enzymatica AB’s price movement after its last earnings report?
Enzymatica AB reported an EPS of -kr0.03 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 2.041%.
Which hedge fund is a major shareholder of Enzymatica AB?
Currently, no hedge funds are holding shares in SE:ENZY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Enzymatica AB
Enzymatica AB (ENZY) is a Swedish biotechnology company specializing in the development and commercialization of innovative health products based on enzymatic technology. The company operates primarily in the healthcare sector, focusing on respiratory health and oral care. Its core products include cold and flu remedies that leverage its proprietary enzyme technology to enhance the body's natural defenses and reduce symptoms, as well as mouth sprays and lozenges aimed at improving oral hygiene and health.
Technical Analysis
Orexo AB
―
AlzeCure Pharma AB
―
Klaria Pharma Holding AB
―
Nanexa AB
―
Enorama Pharma AB
―